country report: philippines · p. monodon p. vannamei i 39 1 0 1 0 0 14 55 ... used, species,...
TRANSCRIPT
Country Report: PhilippinesSimeona E. Regidor and Sonia S. Somga
Aquatic AMR Workshop 1: 10-11 April 2017, Mangalore, India
FMM/RAS/298: Strengthening capacities, policies and national action plans on
prudent and responsible use of antimicrobials in fisheries
PHILIPPINE FISHERIES PRODUCTION (2015)
Sector Quantity (MT) % to Total
1. Aquaculture 2,348,161 50.5%
2. Municipal Fisheries 1,216,526
26.2
3. Commercial Fisheries 1,084,624 23.3
Aquaculture Sector
Species Quantity (MT)
Percent
Seaweeds 1,566,362 66.7
Milkfish 384,425 16.37
Tilapia 261,210 11.12
Shrimps/prawns 52,124 2.22
Others 84,040 3.58
Major Species Produced in Aquaculture Fisheries, 2015
10
1. Siting & Design
2. Facility & Sanitation
3. Water use
4. Farm Mgt.
5. Feeds & Feeding
6. Mortalities
7. Disease
8. Drugs & Chemicals
9. Harvesting & Transport
10. Biodiversity
11. Animal welfare
12. Labor & community
9 Chemical Use
Addresses the issues and requirements on using drugs and
chemicals. It covers the potential risks associated in handling drugs &
chemicals
GAqP- 9. Chemical Use
9.1Veterinary drugs, medicated feeds, chemical andbiological substances should be obtained fromregistered and authorized manufacturers and suppliersand should be used only when necessary.
9.2Veterinary drugs, medicated feeds, chemical and biological substances should only be those permitted and registered according to national regulations.
GAqP- 9. Chemical Use
9.3 Drug residues should not be present in the body of fish by observing withdrawal period to ensure that the maximum residue level (MRL) is acceptable based on the standards set by Codex or trading partners.
9.4 Substances requiring prescription should only be used under adequate supervision by a qualified expert or a trained technician. Non-prescription substances should be used according to manufacturer’s instructions and as specified on the label.
Central
Office
Region III - 32
Region II - 17
Region IX
- 43
Region -
48
Cordillera Autonomous
Region - 7
Region V - 24
Region VIII - 15Region VI - 58
Region VII - 18
Region XI - 15
Region XIII - 3
Region X - 8
Region XII - 14
Region IV - 56
ARMM - 6
Registered Aquaculture Farm as of 31 January 2017
RegionSpecies Cultured Total Number of
Registered Aquaculture FarmMilkfish
ShrimpTilapia Pompano Lobster Polyculture
P. monodon P. vannameiI 39 1 0 1 0 0 14 55II 0 0 1 14 0 0 2 17III 2 0 0 0 1 0 29 32
IV-A 7 2 9 9 0 0 0 27IV-B 0 0 2 2 0 0 25 29
V 0 1 0 2 0 0 21 24VI 32 3 19 0 0 0 4 58VII 1 5 5 0 0 0 7 18VIII 5 5 1 0 0 1 3 15IX 7 1 0 1 0 0 34 43X 0 3 0 0 0 0 5 8XI 5 0 0 3 0 0 7 15XII 2 8 0 0 0 0 4 14
XIII-CARAGA 0 0 0 0 0 0 3 3ARMM 1 0 0 2 0 0 3 6
CAR 0 0 0 6 0 0 1 7TOTAL 101 29 37 40 1 1 162
TOTAL 371
National Residue Monitoring Program
o Drugs/Chemicals that are possibly applied in aquaculture that cause negative effects to the consumer, on-target aquatic species and the environment
17
Detecting all illegal treatments particularly the banned antibiotics
Controlling compliance with the maximum residue limits (MRL) for residue of veterinary drugs and other substances
Specific Objectives:
o BFAR Administrative Circular No. 256, Series of 2015 – Declaring malachite green and gentian violet as health hazards and prohibiting their use in food fish production and trade
o DA Administrative Order No. 14, 2003 – Ban on the use in food animals of beta-agonist Drugs used in humans as bronchodilators and tocolytic agents.
o Department of Health (DOH) and Department of Agriculture (DA) Joint Administrative Order No. 2, Series of 2000 — Declaring ban/phase out of the use of nitrofurans in food-producing animals.
o DOH Administrative Order No. 4-A and DA Administrative Order No. 1, Series 2000 — the banning and withdrawal of olaquindox and carbadox from the market.
o DOH Administrative Order No. 91 and DA Administrative Order No. 60, Series of 1990 — Declaring ban on the use of chlorampenicol in food-producing animals.
18
19
Group A. Substances having anabolic effect and unauthorized substances
Substance Species LOD Action Limit
A1 (Stilbenes) DES ShrimpMilkfishTilapi
0.1 µg/kg Positivedetection
A3 (Steroids) Methyltestosterone
0.05 µg/kg Positivedetection
A6 Chloramphenicol 0.05 µg/kg 0.3 µg/kg
Positivedetection
Nitrofurans(AOZ,AMOZ)
0.10 µg/kg 1.0 µg/kg
Groups of Substances
20
Group of Substance Product Limit of Detection
Level of Action
Group B Substances : Veterinary drugs (1) and contaminants
B1(Antibacterial subs)Chlortetracycline OxytetracyclineSulfamethazineAmoxicillinTrimetoprimSulfadiazineOxolinic acidErythromycin
ShrimpMilkfishTilapia
80 µg/kg80 µg/kg100 µg/kg50 µg/kg50 µg/kg50 µg/kg0.3 µg/kg0.003 µg/kg
100 µg/kg100 µg/kg100µg/kg50µg/kg50 µg/kg100 µg/kg100 µg/kg200 µg/kg
B2a Ivermectin 49 µg/kg 100 µg/kg
21
Group of Substance Product Limit of Detection Level of Action
Group B Substances : Veterinary drugs (1) and contaminants
B1(Antibacterial subs)Chlortetracycline OxytetracyclineSulfamethazineAmoxicillinTrimetoprimSulfadiazineOxolinic acidErythromycin
ShrimpMilkfishTilapia
80 µg/kg80 µg/kg100 µg/kg50 µg/kg50 µg/kg50 µg/kg0.3 µg/kg0.003 µg/kg
100 µg/kg100 µg/kg100µg/kg50µg/kg100µg/kg100 µg/kg100 µg/kg200 µg/kg
B2a Ivermectin 49 µg/kg 100 µg/kg
22
Group of Substance Product Limit of Detection Level of Action
Group B Substances : Veterinary drugs (1) and contaminants
B3a Organochlorines-BHC β-BHCAldrinDieldrinChlordaneDDTDDDDDEEndrinEndosulfan IEndosulfan IIHeptachlorHeptachlor epoxideLindaneMetoxychlor
ShrimpMilkfishTilapia
4 ug/kg 200µg/kg 100 µg/kg 200 µg/kg 200 µg/kg 50 µg/kg 400 µg/kg 400µg/kg 400 µg/kg 50 µg/kg100 µg/kg100 µg/kg200 µg/kg200 µg/kg20 µg/kg10 µg/kg
23
Group of Substance Product Limit of Detection
Level of Action
Group B Substances : Veterinary drugs (1) and contaminants
B3c Heavy metals Mercury Lead Cadmium
5 µg/kg50 µg/kg50 µg/kg
500 µg/kg300 µg/kg50 µg/kg
24
Group of Substance Product Limit of Detection
Level of Action
Group B Substances : Veterinary drugs (1) and contaminants
B3d Aflatoxin Feeds 1.7 µg/kg 20 µg/kg
B3e Malachite & Leucomalachite Green
ShrimpMilkfishTilapia
0.34 µg/kg0.41 µg/kg
Positive detection
25
Residue Monitoring Program
NRMP Plan
Based on EU Directive 96/23EC.
NRMP Target
Regional SamplingSampling and handling
Sampling in meat-farm, consignacion, pro-cessor
Sampling in feeds
Storage and handling
Sample labelling and traceability
26
Farm Registration
Farm source of raw materials
Fish Health Officer
Regional Director
BFAR Director
Inform the FHO
Apply for registration
Registration Form
Farm Inspection
Sampling if necessary
Disease surveillance and residue monitoring
Assessment and assigning of Registration Number
Endorsement for issuance of certificate of registration
Issuance of certificate
Releasing of certificate
Confirmatory
Suspend the registration
Farm Inspection and Sampling
Farm visit and sampling
Laboratory analysis
Positive result
Positive
Negative result
Fish Inspection Unit, Certification Unit and Exporter
Sampling and analysis
Negative result
Positive
Resume Registration
-Farm hygiene-Disease surveillance and residue monitoring
Collect sample/s
27
28
Presence ofBanned substances
On-spot inspection
Absence of Banned substances
BFAR cc BAI
Feedmills
Report to BFAR Director
Recommend to BAI Non-compliance
Collection of feed samples
Laboratory analysis
Non-conforming Conforming
Feedmill Sampling
Use of veterinary medicines in Philippine aquaculture: current statusSSSomga. JRSomga, SERegidor
•Survey in 2009 to determine current range of veterinary medicines applied in aquaculture and assess the perception of respondents on their impacts
•Survey form used was developed by FAO
•Consisted of information about the respondents, types of veterinary medicines and other products used, species, culture system, dosages and availability, efficacy and impact, reasons for treatment failure
•69 respondents from different subsectors of aquaculture production-operators of shrimp and tilapia hatcheries and grow-out; milkfish/marine fish grow-out, gov’t field workers, and feed and aquatic products suppliers
MG Bondad-Reantaso, JR Arthur &RP Subasinghe eds. Improving biosecurity through prudent and responsible use of veterinary medicnes in aquaculture food production
0
2
4
6
8
10
12
14
16A
mox
icill
inD
oxyc
yclin
eEr
ythr
omyc
inEn
roflo
xaci
nFl
orfe
nico
l
Neo
myc
in s
ulfa
teN
orflo
xaci
nO
xyte
tracy
clin
eO
xolin
ic a
cid
Rif
ampi
cin
Sulfa
mon
omet
hoxi
ne
Sulfa
quin
oxal
ine
Trim
etop
hrim
-Sul
fadi
azin
e
Antibiotics
Tilapia grow out
Tilapia hatchery
Milkfish/ Marine fish
grow outShrimp hatchery
31
Association of South-East Asian Nations
(ASEAN)
GUIDELINES FOR THE USE OF
CHEMICALS IN AQUACULTURE
AND MEASURES TO ELIMINATE
THE USE OF HARMFUL
CHEMICALS
Analysis conducted in shrimp (2017)
Analyses No. of sample No. of Positive
1. EHP 127 10
2. AHPND/EMS 157 2
3. WSSV 191 34
4. IHHNV 144 30
5. IMNV 123 0
6. MBV 68 18
7. TSV 141 0
8. NHPB 122 1
9. YHV/GAV 144 1
10. PvNV 90 0
Samples collected by BFAR central and regional laboratories, and submitted by industries
*PL and grow-out stages
BACTERIA IDENTIFIED FROM 2016-2017
API 20ESpecies Bacteria Identified Organs
1Tilapia Enterobacter cloacae Kidney2Red Tilapia Pseudomonas luteola Spleen3Red Tilapia Enterobacter sakazakii Spleen4Red Tilapia Pseudomonas aeroginosa Liver5Siganid Vibrio alginolyticus Kidney6Siganid Vibrio alginolyticus Spleen7Siganid Vibrio alginolyticus Liver8Siganid Escherichia coli 2 Spleen9Eel Pleisomonas shigelloides Liver
API 20 STREP
Species Bacteria Identified Organs1Pompano Streptococcus agalactiae Kidney2Pompano Streptococcus agalactiae Caudal3Pompano Streptococcus agalactiae Brain4Pompano Streptococcus agalactiae Liver5Tilapia Gemella haemolysans Spleen6Tilapia Gemella haemolysans Liver7Tilapia Streptococcus agalactiae Kidney8Tilapia Gemella haemolysans Kidney9Tilapia Streptococcus agalactiae Brain
10Tilapia Streptococcus agalactiae Liver11Tilapia Streptococcus agalactiae Spleen
BACTERIA IDENTIFIED FROM 2016-2017
API STAPH
Species Bacteria Identified Organs1Ornamental Fish Staphylococcus cohnii Kidney
2Discus Staphylococcus cohnii Spleen3Tilapia Micrococcus spp. Liver4Pompano Staphylococcus xylosus Caudal5Pompano Staphylococcus sciuri Speen6Tilapia Staphylococcus xylosus Kidney
7Tilapia Micrococcus spp. Kidney8Red Tilapia Micrococcus spp. Brain
9Tilapia Staphylococcus xylosus Brain10Tilapia Staphylococcus sciuri Brain
11Tilapia Staphylococcus sciuri Spleen12Tilapia Staphylococcus xylosus Kidney13Eel Staphylococcus haemolyticus Spleen14Eel Staphylococcus aureus Kidney15Red Tilapia Staphylococcus capitis Liver
BACTERIA IDENTIFIED FROM 2016-2017
API 20NESpecies Bacteria Identified No. Species Bacteria Identified No.
1 Ornamental Fish Aeromonas hydrophila/caviae Spleen 20 Tilapia Vibrio cholerae Kidney
2 Discus Shiwanella putrefaciens Liver 21 Tilapia Aeromonas hydrophila/caviae Brain
3 Discus Shiwanella putrefaciens Spleen 22 Tilapia Vibrio cholerae Liver
4 Discus Aeromonas sobria Spleen 23 Tilapia Aeromonas sobria Kidney
5 Tilapia Aeromonas sobria 3 24 Tilapia Aeromonas hydrophila/caviae 5
6 Tilapia Aeromonas sobria Liver 25 Tilapia Aeromonas sobria Kidney
7 Pompano Vibrio alginolyticus 2 26 Tilapia Aeromonas sobria Brain
8 Pompano Vibrio parahaemolyticus 3 27 Tilapia Plesiomonas shigelloides Brain
9 Pompano Photobacterium damselae Kidney 28 Eel Aeromonas sobria Kidney
10 Pompano Vibrio alginolyticus Brain 29 Eel Aeromonas hydrophila/caviae Kidney
11 Pompano Vibrio parahaemolyticus Liver 30 Red tilapia Aeromonas hydrophila/caviae Brain
12 Pompano Vibrio alginolyticus Liver 31 Eel Burkholderia cepacia Liver
13Pompano
Aeromonas hydrophila/caviae Liver 32Ornamental Fish
Aeromonas hydrophila/caviae Liver
14 Pompano Vibrio spp. 2 33 Eel Aeromonas hydrophila/caviae Kidney
15 Pompano Vibrio parahaemolyticus Caudal 34 Eel Vibrio alginolyticus Kidney
16 Tilapia Aeromonas sobria Fin 35 Eel Aeromonas hydrophila/caviae 2
17 Tilapia Shiwanella putrefaciens Kidney 36 Eel Shiwanella putrefaciens Liver
18 Tilapia Aeromonas hydrophila/caviae Muscle 37 Eel Aeromonas sobria Liver
19 Tilapia Aeromonas sobria 2 36 Eel Shiwanella putrefaciens Liver37 Eel Aeromonas sobria Liver
Objective Activity Measurement Responsible Agency
1. To develop programs and systems for surveillance and monitoring of AMR
Development of surveillance and monitoring system for AMR and AMU in food-producing animals
Manual of procedures and harmonized standards; AMR/AMU reports in animalspecies;protocols for reporting system and feedback system
DA (BAI and BFAR
Data collection/sampling/testing/analysis of drug residue in animals (focus on AMR)
Data collected samples tested/analyzed and results reviewedA report on the occurrence of AMR in animal species and on production practices relevant to the emergence of AMR
DA (BAI and BFAR
Key Strat 2: Strengthen surveillance and laboratory capacity
Objective Activity Measurement Responsible Agency
1. To develop programs and systems for surveillance and monitoring of AMR
Sampling and testing analysis for antibiotic susceptibility testing based on internationally accepted standard
Reports on AMR in animal species
DA (BAI and BFAR
Monitoring of AMR and AMU trends in food producing animals
Regular dissemination of reports on AMR in animal species
DA (BAI and BFAR
Key Strat 3. Ensure uninterrupted access to essential medicines of assured quality
Objective Activity Measurement Responsible agency
To improve the registration, marketing authorization and post marketing surveillance of antimicrobials
Process streamlining of review and release of marketing of new antibiotics that address priority infectious diseases in the country
Protocols for facilitated processes of review and marketing authorization of new antibiotics available in websites; issuance of certificate of product registration, LTO for antimicrobials and importation clearance
DOH (FDA) and DA (BAI, BFAR and OPP)
Key Strat 3. Ensure uninterrupted access to essential medicines of assured quality
Objective Activity Measurement Responsible agency
Forging an agreement on regulatory control over drugs used in aquaculture
Approved joint AO including sanctions on products with positive antibiotic residue
DOH (FDA) and DA (BFAR)
Rationalization and harmonization of regulatory control over the manufacture and use of antibiotics in animals
Agreed policy between DA and DOH; Enactmentof animal industry and veterinary services act
DOH (FDA) and DA (BFAR)
Key Strat 3. Ensure uninterrupted access to essential medicines of assured quality
Objective Activity Measurement Responsible agency
Develop database of registeredantimicrobials, including quantitative production and importation
Database available in website
DA (BAI and BFAR)and DOH (FDA)
Quality monitoring of veterinary drugs
Quality reports DA (BAI and BFAR)and DOH (FDA)
Objective Activity Measurement
Responsible agency
To ensure access to essential medicine
Forging of partnership with healthcare professionals, organization and consumer group
MOA/MOU DOH (FDA) and DA (BAI and BFAR)
Review of issuances related to access to antimicrobials, especially in the distribution and sale in drug outlet
Reports; minutes of meeting
DA (BAI and BFAR)and DOH (FDA)
Strict enforcement of regulation on antibiotic prescription, dispensing and use
Monitoring reports
DA (BAI and BFAR
Key Strat 4. Regulate and promote rational use of medicine in humans and animal health sectors
Objective Activity Measurement
To foster enablingenvironment for the rational use of medicines
Conduct of coordination meeting and workshops for implementation of policies with local government
Status report on the strengthening of variousregulations for vet drugs; compedium of relevant laws, AOs and circulars
Review of existing regulatory controls for registration, advertising and importation and end use
Compliance report
Improve implementation and policy on prescribing and dispensing veerinary drugs (VDO
Key Strat 5. Enhance infection prevention and control across all settings
Objective Activity Measurement Responsible agency
Toimplement programs on IPC
Implementation of Good Husbandry Practices (GAHP) and Good Aquaculture Practices as Phil National Standard
Training sessions conducted, number of farm registered with GAqP, validation of codes of good practices (audits and renewal)
Strengthen animal health capacity
Workshops conducted/info materials disseminated on implementation of relevant policies on proper use of antimicrobials
ACKNOWLEDGEMENTS
o THANKS TO FAO FOR MAKING THIS PROJECT POSSIBLE
o CORDIAL RATITUDE FOR INCLUDING THE PHILIPPINES IN THE PROJECT AND THE ISSUE ON ANTIMICROBIAL IN AQUACULTURE IS NEW TO THE PHILIPPINES
o THANKS MELBA REANTAZO FOR ENSURING OUR PARTICIPATION IN THIS ACTIVITY